IE
VIVE

Israel Englander’s VIVEVE MED INC VIVE Stock Holding History

Israel Englander’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,889
Closed -$11K – 7731
2022
Q2 		$11K Sell
16,889
-2,712
-14% -$2.31K ﹤0.01% 6666
2022
Q1 		$21K Sell
19,601
-9,114
-32% -$9.13K ﹤0.01% 6633
2021
Q4 		$32K Buy
+28,715
New +$52.7K ﹤0.01% 6561
2018
Q4 		– Sell
-25
Closed -$66K – 4326
2018
Q3 		$66K Sell
25
-32
-56% -$90.7K ﹤0.01% 3784
2018
Q2 		$155K Buy
+57
New +$164K ﹤0.01% 3604
2017
Q4 		– Sell
-18
Closed -$96K – 4181
2017
Q3 		$96K Buy
+18
New +$111K ﹤0.01% 3361
2017
Q2 		– Sell
-63
Closed -$396K – 3997
2017
Q1 		$396K Buy
+63
New +$306K ﹤0.01% 2919

Other funds holding VIVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Israel Englander's VIVE Position: Q3 2022 in Review

Israel Englander sold out of VIVEVE MED INC (VIVE) in Q3 2022, closing a stake of 16,889 shares — an estimated $11K sold.

Israel Englander first reported a position in VIVE in Q1 2017 and held it in 7 quarters. The position peaked at $396K in Q1 2017. 15 funds tracked by Wall St. Rank hold VIVE as of Q3 2022.

  • Israel Englander reported no remaining VIVEVE MED INC position as of Q3 2022 after selling out during the quarter.
  • Israel Englander sold 16,889 VIVEVE MED INC shares in Q3 2022, an estimated $11K.
  • Israel Englander first reported a position in VIVEVE MED INC in Q1 2017 and held it in 7 quarters.
  • Israel Englander's VIVEVE MED INC position peaked at $396K in Q1 2017.
  • 15 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.